What is Suzhou Highfine Biotech Co., Ltd.'s (301393.SZ) StockRank?

MoatMap's StockRank for Suzhou Highfine Biotech Co., Ltd. (301393.SZ) is 55/100, with a Hold signal. This is a composite score combining Quality (60), Value (26), and Momentum (59) factor ranks across MoatMap's 19,000+ stock universe.

Does Suzhou Highfine Biotech Co., Ltd. have an economic moat?

Suzhou Highfine Biotech Co., Ltd. (301393.SZ) has a Quality factor score of 60/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Suzhou Highfine Biotech Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Suzhou Highfine Biotech Co., Ltd. (301393.SZ) is Hold, based on a StockRank of 55/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Suzhou Highfine Biotech Co., Ltd. in?

Suzhou Highfine Biotech Co., Ltd. (301393.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

301393.SZ

HOLDFLAG

Suzhou Highfine Biotech Co., Ltd. · Healthcare · China · $896M · Avg Vol: $15M/d

StockRank

P/E (TTM)

48.2x

ROE

4.6%

D/E

0.0x

Dividend %

0.8%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Suzhou Highfine Biotech provides peptide reagents and CDMO services, positioning it directly in the path of the massive global GLP-1 demand wave. However, geopolitical headwinds for Chinese biotech suppliers limit our ability to make this a high-conviction holding.

COMPANY DESCRIPTION

Suzhou Highfine Biotech Co., Ltd. is a specialized chemical manufacturer producing peptide synthesis reagents, linkers for antibody-drug conjugates (ADCs), and pharmaceutical intermediates. The company's competitive moat is its high-purity chemical synthesis technology and strict quality control, making it a trusted supplier to global pharmaceutical and biotech firms. It is a critical niche player in the global macromolecular drug R&D and manufacturing supply chain.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	66M	57M	67M	89M	10.4%
EPS	0.24	0.16	0.18	0.16	-12.6%
Shares	81M	108M	108M	108M	+33.3%
Debt	211,127	230,011	484,960	8M	230.0%
Equity	71M	327M	335M	348M	69.6%
Op CF	20M	13M	19M	11M	-17.6%
Inv CF	-14M	-84M	-139M	14M	—
Fin CF	-3M	241M	-12M	-18M	—

PRICE (1M)-13.7%

SMA 50SMA 200

$7.57

RSI (14)

32.1

52W High

$9.79

From 52W High

0.8%

SCORE BREAKDOWN

Quality

ROIC

5.4%58.0

ROE

4.6%55.2

GP/Assets

8.0%23.0

Op. Margin

18.9%80.8

FCF/Assets

-3.3%39.8

Piotroski

—83.5

Int. Cover

50.0x91.4

D/E Ratio

0.04x76.8

Current Ratio

5.41x72.9

Value

P/E (TTM)

48.2x21.3

EV/EBITDA

28.1x12.4

P/FCF

—N/A

P/B

2.3x50.7

P/S

8.6x29.3

Div Yield

0.8%22.2

Momentum

52W High %

77%70.1

RS 6M

-4%74.4

SMA 50/200

1.06x73.2

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

-4%36.8

FUNDAMENTALS

Market Cap

$896M

P/E (Forward)

—

Gross Margin

33.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 301393.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
301393.SZ	Suzhou Highfine Biotech Co., Ltd.(you)	$896M	55	HOLD
300401.SZ	Zhejiang Garden Biopharmaceutical Co.,Ltd.	$984M	54	HOLD
300119.SZ	Tianjin Ringpu Bio-Technology Co.,Ltd.	$1.1B	55	HOLD
688799.SS	Hunan Warrant Pharmaceutical Co.,Ltd	$975M	50	HOLD
688505.SS	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.	$1.1B	52	HOLD
688073.SS	Bide Pharmatech Co., Ltd.	$683M	57	HOLD
2186.HK	Luye Pharma Group Ltd.	$1.1B	61	HOLD
688117.SS	ChengDu ShengNuo Biotec Co.,Ltd.	$785M	48	HOLD
000597.SZ	Northeast Pharmaceutical Group Co., Ltd.	$983M	64	HOLD
600195.SS	China Animal Husbandry Industry Co., Ltd.	$996M	64	HOLD

Peer medians: ROE 4.8% · P/E 27.6x · Gross margin 53.1%

Suzhou Highfine Biotech Co., Ltd. (301393.SZ) — Stock Score Summary

Suzhou Highfine Biotech Co., Ltd. (301393.SZ) has a MoatMap StockRank of 55/100 based on Quality (60/100), Value (26/100), and Momentum (59/100) factor scores. The current signal is HOLD. Suzhou Highfine Biotech provides peptide reagents and CDMO services, positioning it directly in the path of the massive global GLP-1 demand wave. However, geopolitical headwinds for Chinese biotech suppliers limit our ability to make this a high-conviction holding.

Key Financial Metrics

Price	$7.57
Market Cap	$896M
P/E (TTM)	48.22
Price/Book	2.27
Return on Equity	4.6%
Return on Invested Capital	5.4%
Debt/Equity	3.67
Gross Margin	33.1%
Operating Margin	18.9%
Revenue Growth	27.2%
Dividend Yield	0.8%
Free Cash Flow	$-2M

Suzhou Highfine Biotech Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Suzhou Highfine Biotech Co., Ltd.’s (301393.SZ) StockRank?: MoatMap’s StockRank for Suzhou Highfine Biotech Co., Ltd. (301393.SZ) is 55/100, with a Hold signal. It is a composite of Quality (60), Value (26), and Momentum (59) factor ranks across MoatMap’s 19,000+ stock universe.
Does Suzhou Highfine Biotech Co., Ltd. have an economic moat?: Suzhou Highfine Biotech Co., Ltd. (301393.SZ) has a Quality factor score of 60/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Suzhou Highfine Biotech Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Suzhou Highfine Biotech Co., Ltd. (301393.SZ) is Hold, based on a StockRank of 55/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Suzhou Highfine Biotech Co., Ltd. in?: Suzhou Highfine Biotech Co., Ltd. (301393.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).